ConAlliance

What ConAlliance does

ConAlliance is a Munich-headquartered, privately held M&A advisory firm that operates exclusively across the international healthcare and life sciences sector. Founded in 2010 and controlled by Managing Partner and Inhaber (owner) Günter Carl Hober, the firm is registered in Germany as a sole proprietorship (ConAlliance Günter Hober Einzelunternehmen) alongside wholly owned operating entities ConAlliance SPV I GmbH (Munich), ConAlliance UK Ltd. (London), and CA Holding GmbH (Innsbruck). With 11–50 employees distributed across offices in Munich, London, Copenhagen, Chicago, Singapore, Hong Kong, Tokyo, and Innsbruck, the firm positions itself as a healthcare-specialist boutique offering the full transaction lifecycle from target identification through closing.

The firm's service catalogue is organized around three practice areas: Mergers & Acquisitions Advisory (company sales, acquisitions, succession planning, licensing, cooperation, patent/technology sale, target screening), Corporate Finance (exit preparation, financing, growth financing, buy-out/buy-in, distressed M&A), and Expertise/Due Diligence (commercial, technology, ESG due diligence, business valuation, market research, real-estate appraisal). These are delivered through three 'Healthcare Intelligence' verticals — Medical Technology, Healthcare Services, and Life Sciences — covering sub-sectors such as MedTech devices, diagnostics, pharma, biotech, telemedicine, care services, CDMO/CRO, and healthcare logistics. The team combines business-trained partners with doctors, lab experts, engineers, and lawyers to perform technical diligence that generalist advisors cannot, and the Managing Partner personally references more than 300 transaction and strategy projects completed during his career.

ConAlliance generates revenue through professional services fees on individual M&A mandates, with quote-based custom engagement pricing (no publicly disclosed rate cards). It sells both buy-side and sell-side mandates to enterprise healthcare corporates (e.g., Nestlé, Fujifilm, IQVIA, Embla Medical, Erbe Elektromedizin, Wacker Chemie, Bertelsmann, VitalAire), growth-stage life-science companies (e.g., BBS-Bioactive Bone Substitutes), and private equity funds (e.g., Agilitas Private Equity). Distribution is direct, partner-led, and referral-driven — anchored in industry reputation, multi-year awards from Financial Times, ACQ5, M&A Today, Finance Monthly, and others, and website-published deal announcements. The firm has cumulatively completed over 250 healthcare transactions and reports no external institutional investors or public-listing activity.

Name

ConAlliance

Legal name

ConAlliance Günter Hober Einzelunternehmen

Website

https://conalliance.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

ConAlliance is a Munich-headquartered, privately held M&A advisory firm specializing exclusively in international healthcare and life sciences transactions, serving enterprise healthcare corporates, private equity funds, and family-owned healthcare businesses with buy-side, sell-side, succession, and distressed M&A mandates across global markets.

Ownership category

akta.pro rank

Product category

Healthcare M&A Advisory

NAICS

Management Consulting Services (54161), Professional, Scientific, and Technical Services (54)

SIC

Services-Management Consulting Services (8742), Services-Engineering, Accounting, Research, Management (8700)

akta.pro primary industry

M&A Advisory (Buy-Side & Sell-Side) (BPAHAOAA)

akta.pro secondary industries

Corporate Development & Strategic Partnerships Advisory (JVs, Alliances, Carve-outs) (BPAHAOAG), Sustainability & ESG Consulting (BPAHACAK), Mergers, Acquisitions & Spin-offs Event Administration (FSACAKAG)

Keywords

• Healthcare M&A advisory
• Life sciences consulting
• Transaction advisory services
• Medical technology advisory
• Biotech investment banking

Headquarters

HQ city

Munich

HQ country

Germany

HQ region

Europe

Offices9 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. M&A Advisory Services: Professional services revenue from advising on mergers, acquisitions, company sales and purchases in the healthcare sector. Services include due diligence reports, company valuations, M&A strategy development, and transaction support.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

ConAlliance provides M&A advisory, corporate finance, and due diligence services exclusively to the healthcare and life sciences sector. The firm advises on company sales, acquisitions, succession planning, patent and technology sales, acquisition target screening, and distressed M&A transactions. Engagement is delivered through senior partners who combine industry expertise with multidisciplinary teams covering medical, engineering, legal, and financial perspectives.

Product overview

ConAlliance is an international M&A advisory firm specializing exclusively in the healthcare and life sciences sector. The firm operates as a unified consulting practice offering advisory services across the entire transaction lifecycle. Core service lines include Mergers & Acquisitions Advisory (company sales, acquisitions, licensing, cooperation), Corporate Finance (exit preparation, financing, growth financing, buy-out/buy-in, distressed M&A), and Due Diligence Services (commercial, technology, ESG due diligence, valuation, market research). These services are delivered through specialized Healthcare Intelligence verticals covering Medical Technology, Healthcare Services, and Life Sciences sectors. The firm also offers specific offerings such as Succession Planning, Patent and Technology Sale, and Acquisition Target Screening. ConAlliance functions as a professional services firm rather than a software product company.

Differentiator

Problem solved

Functional benefit

Products and services

• Mergers & Acquisitions Advisory Buy-side and sell-side M&A advisory exclusively for healthcare and life sciences companies, including the identification of acquirers and targets, deal structuring, negotiation, and transaction closing support.
• Corporate Finance Advisory Capital-raising and corporate finance advisory for healthcare and life sciences companies, including financing structures, capital sourcing, and balance-sheet advisory for transactions.
• Due Diligence Services Sector-specialized due diligence on healthcare and life sciences targets, covering clinical, regulatory, IP, and commercial diligence dimensions together with financial diligence coordination for investors and corporate acquirers.
• Succession Planning Advisory for founders, owner-families, and healthcare entrepreneurs on transferring ownership of their businesses via M&A, including preparation, valuation, and buyer-screening for succession-driven transactions.
• Patent and Technology Sale Advisory on the sale and licensing of healthcare and life sciences patents, technologies, and IP-driven assets to corporate and financial buyers.
• Acquisition Target Screening Systematic identification, mapping, and prioritization of acquisition targets in the healthcare and life sciences sector for corporate and financial buyers, supported by ConAlliance's Healthcare-Intelligence market-mapping capability.
• Distressed M&A Advisory on M&A transactions involving distressed or under-pressure healthcare and life sciences businesses, including insolvency-related and turnaround-driven deal structures.

Named customers12 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Jefferies Healthcare Group: Dedicated healthcare investment banking franchise within Jefferies providing M&A, equity, and debt advisory to pharma, MedTech, and life sciences companies; comparable in healthcare specialization but with far greater resources and bulge-bracket capacity.
• Canaccord Genuity Healthcare: Healthcare and life sciences investment banking team at Canaccord Genuity advising MedTech, biotech, and pharma companies on M&A and capital markets; comparable in healthcare-only focus and mid-market positioning.
• Outcome Capital: US-based boutique life sciences and healthcare M&A advisory firm providing strategic advisory, capital raising, and transaction services to MedTech, biotech, diagnostics, and digital health companies — directly comparable to ConAlliance's exclusive healthcare focus, though tilted to the US market.
• Piper Sandler Healthcare: Healthcare-focused investment banking group within Piper Sandler serving MedTech, pharma services, and life sciences companies with M&A advisory; directly comparable in vertical specialization, though operating at larger scale.
• Guggenheim Securities Healthcare: Healthcare investment banking franchise of Guggenheim Securities providing M&A advisory to pharma, MedTech, and life sciences clients; directly comparable as a healthcare-specialized M&A advisor, with a US-centric base.

Broad incumbents

• L.E.K. Consulting: Global management consulting firm with a large healthcare and life sciences practice that provides commercial due diligence and M&A support; comparable in healthcare expertise and due diligence services, but operating as a broader strategy consultancy rather than pure M&A advisor.
• EY-Parthenon Healthcare: Strategy and transactions arm of EY with a dedicated healthcare practice providing M&A advisory, commercial due diligence, and integration services; competes for healthcare M&A mandates across Europe and globally, but as part of a multi-sector Big Four firm.
• Deloitte Healthcare M&A: Deloitte's life sciences and healthcare M&A advisory practice serving MedTech, pharma, and healthcare services clients; comparable buyer/seller advisory work, with much larger global scale and cross-functional capabilities.
• KPMG Healthcare Deal Advisory: Big Four firm with a healthcare-focused M&A and deal advisory practice that competes in the same European and global healthcare transaction market as ConAlliance, but offers far broader service lines and balance-sheet scale.

Emerging players

• MedWorld Advisors: Boutique M&A advisory firm focused on MedTech and healthcare companies globally; directly comparable as a healthcare-exclusive M&A boutique, with similar mid-market positioning and cross-border reach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ConAlliance